CAREDX, INC. Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
CAREDX, INC. (CDNA) reported Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$33.24 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest · last filed 2022-02-24
- CAREDX, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-12-31 was -$4.05M.
- CAREDX, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-09-30 was -$2.68M.
- CAREDX, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-06-30 was -$7.92M.
- CAREDX, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-03-31 was -$8.26M.
- CAREDX, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2021 was -$33.24M.
- CAREDX, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2020 was -$15.61M.
- CAREDX, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2019 was -$22.89M.
- CAREDX, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2018 was -$48.71M.
| Period end | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|
| 2021-12-31 | -$33.24M 10-K · filed 2022-02-24 | |||||
| 2020-12-31 | -$15.61M 10-K · filed 2022-02-24 | |||||
| 2019-12-31 | -$4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$6.72M derived: sum of 2 quarters · filed 2022-02-24 | -$14.64M derived: sum of 3 quarters · filed 2022-02-24 | -$22.89M 10-K · filed 2022-02-24 | ||
| 2019-09-30 | -$2.68M 10-Q · filed 2019-10-31 | -$10.59M derived: sum of 2 quarters · filed 2019-10-31 | -$18.85M 10-Q · filed 2019-10-31 | -$22.89M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-06-30 | -$7.92M 10-Q · filed 2019-08-01 | -$16.17M 10-Q · filed 2019-08-01 | -$20.22M derived: sum of 3 quarters · filed 2021-02-24 | -$40.07M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-03-31 | -$8.26M 10-Q · filed 2019-05-08 | -$12.30M derived: sum of 2 quarters · filed 2021-02-24 | -$32.15M derived: sum of 3 quarters · filed 2021-02-24 | -$47.84M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2018-12-31 | -$4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$23.90M derived: sum of 2 quarters · filed 2021-02-24 | -$39.58M derived: sum of 3 quarters · filed 2021-02-24 | -$48.71M 10-K · filed 2021-02-24 | ||
| 2018-09-30 | -$19.85M 10-Q · filed 2019-10-31 | -$19.85M 10-Q · filed 2018-11-08 | -$35.54M derived: sum of 2 quarters · filed 2019-10-31 | -$44.67M 10-Q · filed 2019-10-31 | -$44.67M 10-Q · filed 2018-11-08 | -$76.45M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | -$15.69M 10-Q · filed 2019-08-01 | -$24.82M 10-Q · filed 2019-08-01 | -$56.60M derived: sum of 3 quarters · filed 2020-02-28 | -$70.36M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-03-31 | -$9.13M 10-Q · filed 2019-05-08 | -$40.91M derived: sum of 2 quarters · filed 2020-02-28 | -$54.67M derived: sum of 3 quarters · filed 2020-02-28 | -$58.04M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2017-12-31 | -$31.78M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$45.54M derived: sum of 2 quarters · filed 2020-02-28 | -$48.91M derived: sum of 3 quarters · filed 2020-02-28 | -$54.25M 10-K · filed 2020-02-28 | ||
| 2017-09-30 | -$13.76M 10-Q · filed 2018-11-08 | -$17.13M derived: sum of 2 quarters · filed 2018-11-08 | -$22.47M 10-Q · filed 2018-11-08 | -$40.08M derived: sum of 4 quarters · filed 2019-03-06 | ||
| 2017-06-30 | -$3.37M 10-Q · filed 2018-08-09 | -$8.71M 10-Q · filed 2018-08-09 | -$26.32M derived: sum of 3 quarters · filed 2019-03-06 | -$30.54M derived: sum of 4 quarters · filed 2019-03-06 | ||
| 2017-03-31 | -$5.34M 10-Q · filed 2018-05-10 | -$22.95M derived: sum of 2 quarters · filed 2019-03-06 | -$27.17M derived: sum of 3 quarters · filed 2019-03-06 | -$39.07M derived: sum of 4 quarters · filed 2019-03-06 | ||
| 2016-12-31 | -$17.61M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$21.83M derived: sum of 2 quarters · filed 2019-03-06 | -$33.73M derived: sum of 3 quarters · filed 2019-03-06 | -$43.48M 10-K · filed 2019-03-06 | ||
| 2016-09-30 | -$4.22M 10-Q · filed 2017-11-09 | -$16.12M derived: sum of 2 quarters · filed 2017-11-09 | -$25.88M 10-Q · filed 2017-11-09 | -$30.64M derived: sum of 4 quarters · filed 2018-03-22 | ||
| 2016-06-30 | -$11.90M 10-Q · filed 2017-08-11 | -$21.65M 10-Q · filed 2017-08-11 | -$26.41M derived: sum of 3 quarters · filed 2018-03-22 | -$29.90M derived: sum of 4 quarters · filed 2018-03-22 | ||
| 2016-03-31 | -$9.75M 10-Q · filed 2017-06-09 | -$14.51M derived: sum of 2 quarters · filed 2018-03-22 | -$18.00M derived: sum of 3 quarters · filed 2018-03-22 | -$21.19M derived: sum of 4 quarters · filed 2018-03-22 | ||
| 2015-12-31 | -$4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | -$8.25M derived: sum of 2 quarters · filed 2018-03-22 | -$11.44M derived: sum of 3 quarters · filed 2018-03-22 | -$13.71M 10-K · filed 2018-03-22 | ||
| 2015-09-30 | -$3.49M 10-Q · filed 2016-11-14 | -$6.67M derived: sum of 2 quarters · filed 2016-11-14 | -$8.95M 10-Q · filed 2016-11-14 | |||
| 2015-06-30 | -$3.19M 10-Q · filed 2016-08-22 | -$5.46M 10-Q · filed 2016-08-22 | ||||
| 2014-12-31 | $781.00K 10-K · filed 2017-04-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |